Key takeaways: Children and adolescents treated with doxorubicin had superior long-term heart function if they also received dexrazoxane. Dexrazoxane had increased benefit among those treated with ...

Pfizer isn’t stopping to smell the roses on its speed run to secure a full FDA approval for its Braftovi combination therapy.

Doxorubicin is an anthracycline chemotherapy drug that works by interfering with the DNA of a cancer cell to prevent it from replicating. Learn about uses, delivery, side effects, and more.

Mitoxantrone hydrochloride was the first FDA-approved medication for both secondary-progressive multiple sclerosis (MS) and progressive-relapsing MS.

The Takeaway In the article 12 that accompanies this editorial, exposure to doxorubicin during treatment for Hodgkin lymphoma has been shown to increase the subsequent risk of breast cancer in women, ...

Studies in childhood cancer survivors have shown that doxorubicin exposure may also increase BC risk. Although doxorubicin is the cornerstone of HL chemotherapy, the association between doxorubicin ...

The chemotherapy drug mitoxantrone can treat MS by destroying white blood cells that attack myelin and reducing damage to your central nervous system.

Anthracycline drugs prevent cancer cells from reproducing. It can treat several types of cancer, but it can cause a range of side effects. Read more here.

Study: Mitoxantrone modulates a glycosaminoglycan-spike complex to inhibit SARS-CoV-2 infection. Image Credit: Dotted Yeti/ Shutterstock This news article was a review of a preliminary scientific ...

The efficacy and safety of cabazitaxel, as compared with an androgen-signaling–targeted inhibitor (abiraterone or enzalutamide), in patients with metastatic castration-resistant prostate cancer ...

Daunorubicin appeared associated with a lower cardiomyopathy risk than doxorubicin among childhood cancer survivors, according to a multicenter cohort study published in JAMA Oncology.Results also ...

MDA-MB231 cells, the most studied line of TNBC cells, were submitted to selection treatment with mitoxantrone (Mitox) and doxorubicin (DOX).